Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RPh201 for Hard to Heal Chronic Ulcerated Wounds
NCT01429519Phase 2Terminated
- Sponsor
- Regenera Pharma
- Start
- Dec 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RPh201 in Chronic wound, sponsored by Regenera Pharma. Started Dec 2011; status: terminated.
02
Drugs
RPh201
03
Conditions
Chronic wound
Beyond the preview
Go deeper on NCT01429519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01429519.